Dishman Pharmaceuticals & Chemicals (Delisted) share news and announcements

BSE: 532526

Last traded ₹301.20 on 29 May 2017

Delisted on 8 Jan 2018.

Last results date

The last board meeting held for results; the company has not yet given notice of the next.Dishman Pharmaceuticals & Chemicals quarterly results

May16Tue

The board met on 16 May 2017 to consider results

Notice filed 8 May 2017

Inter alia, to consider and take on record the Audited Financial Results of the Company for the quarter and year ended on March 31, 2017. (opens in a new tab)

Dishman Pharmaceuticals & Chemicals annual reports, presentations and earnings calls

The company's own documents, latest first.Dishman Pharmaceuticals & Chemicals financials, year by year

Annual reports14

Annual report, year to Mar 2017 (opens in a new tab)5 Sep 2017
Annual report, year to Mar 2016 (opens in a new tab)28 Sep 2016
Annual report, year to Mar 2015 (opens in a new tab)4 Sep 2015
Annual report, year to Mar 2014 (opens in a new tab)5 Aug 2014
Annual report, year to Mar 2013 (opens in a new tab)9 Jul 2013

9 earlier reports

Annual report, year to Mar 2012 (opens in a new tab)31 Aug 2012
Annual report, year to Mar 2011 (opens in a new tab)30 Jun 2011
Annual report, year to Mar 2010 (opens in a new tab)Filing day not known
Annual report, year to Mar 2009 (opens in a new tab)Filing day not known
Annual report, year to Mar 2008 (opens in a new tab)Filing day not known
Annual report, year to Mar 2007 (opens in a new tab)Filing day not known
Annual report, year to Mar 2006 (opens in a new tab)Filing day not known
Annual report, year to Mar 2005 (opens in a new tab)Filing day not known
Annual report, year to Mar 2004 (opens in a new tab)Filing day not known

Investor presentations5

Kindly find enclosed herewith Presentation on financial result for the quarter ended 30th June, 2017 made to Analyst and Investors. (opens in a new tab)11 Aug 2017
Investor Presentation (opens in a new tab)17 May 2017, a zip file
Investor Presentation (opens in a new tab)14 Feb 2017, a zip file
INVESTORS PRESENTATION ON UNAUDITED FINANCIAL RESULT REGULATION: 30 (opens in a new tab)28 Oct 2016, a zip file
Investors Presentation on Unadudited Financial Results for the Quarter ended June 30, 2016. (opens in a new tab)4 Aug 2016, a zip file

Earnings calls7

2 earlier call documents

Transcript of Conference Call (opens in a new tab)25 May 2016
Transcript of Conference Call (opens in a new tab)10 Feb 2016

Dishman Pharmaceuticals & Chemicals share news and announcements

747 announcements, routine notices left out, newest first. Page 1 of 15.

Sep 2017
Aug 2017
Jul 2017
Jun 2017
- 9 Jun · Updates
  In respect your email dated 31st May, 2017 in respect of discrepancies in financial results of the Company for the quarter/year ended March, 2017 - i.e. financial results for the quarter .... (opens in a new tab)
- 6 Jun · Outcome of Committee Meeting
  We hereby inform you that the Management Committee of Board of Directors of Dishman Carbogen Amcis Ltd., vide resolution passed in their meeting held on today i.e. on 6th June, 2017, have .... (opens in a new tab)
May 2017
- 22 May · Suspension of Trading
  Members of the Exchange are hereby informed that the trading in Equity Shares of Dishman Pharmaceuticals and Chemicals Limited shall be suspended w.e.f. May 30, 2017 (i.e. closing hours of trading on May 29, 2017) on account of Scheme of Amalgamation of Dishman Pharmaceuticals and Chemicals Limited with Carbogen Amcis (India) Limited.
- 19 May · Corporate action
  Board of directors of Amalgamated entity i.e Dishman Carbogen Amcis Limited, in its meeting held on May 19, 2017 has fixed Record Date as May 31, 2017 for the purpose of deciding the members who shall be eligible for allotment of equity shares of the amalgamated entity, Dishman Carbogen Amcis Limited to the shareholders of erstwhile Dishman Pharmaceuticals and Chemicals Limited ("DPCL") in the ratio of 1:1 i.e. Share Exchange Ratio [1 (One) fully paid-up Equity Share of Rs.2/- (Rupees Two only) each of DCAL, for every 1 (One) fully paid-up Equity Share of Rs.2/ (Rupees Two only) each held by such shareholder in DPCL], fixed under the Scheme of Arrangement and Amalgamation approved by the Hon'ble High Court of Gujarat. (opens in a new tab)
- 19 May · Business
  Management Committee of Board of Directors of amalgamated entity i.e. DISHMAN .... (opens in a new tab)
- 17 May · Board meeting
  Meeting of the Management Committee of Board of Directors of amalgamated entity i.e. DISHMAN CARBOGEN AMCIS LIMITED ( DCAL ) [formerly known as Carbogen Amcis (India) Ltd.] will be held on May 19, 2017 inter alia, to fix the Record Date for the purpose of deciding the members who shall be eligible for allotment of equity shares of Dishman Carbogen Amcis Limited to the shareholders of Dishman Pharmaceuticals and Chemicals Limited in the ratio of 1:1 i.e. Share Exchange Ratio, fixed under the Scheme of Merger approved by the Hon ble High Court of Gujarat. (opens in a new tab)
- 16 May · Corporate action
  We hereby inform that the meeting of the Management Committee of Board of Directors of amalgamated entity i.e. DISHMAN CARBOGEN AMCIS LIMITED ('DCAL') [formerly known as Carbogen Amcis .... (opens in a new tab)
- 16 May · Results
  Financial results for the period ended March 31, 2017. (opens in a new tab)
- 16 May · Results
  With reference to the above, we hereby inform that a Meeting of the Board of Directors of the Company was held today i.e. on Tuesday, the 16th day of May, 2017 which was commenced at 04:00 .... (opens in a new tab)
- 15 May · Updates
  This is to inform that pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, the Company has arranged .... (opens in a new tab)
- 15 May · Analysts
  Analysts/Institutional Investor Meet/Con. Call Updates (opens in a new tab)
- 8 May · Board meeting
  Inter alia, to consider and take on record the Audited Financial Results of the Company for the quarter and year ended on March 31, 2017. (opens in a new tab)
- 8 May · Board Meeting On 16Th May, 2017
  We hereby inform you that the meeting of the Board of Directors of the Company will .... (opens in a new tab)
Apr 2017
- 21 Apr · Disclosure
  Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, .... (opens in a new tab)
- 20 Apr · STATEMENT OF INVESTORS COMPLAINTS FOR THE QUARTER ENDED 31/03/2017
  ('Listing Regulations'), we are submitting herewith .... (opens in a new tab)
- 20 Apr · Shareholding for the Period Ended March 31, 2017
  Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click ....
- 18 Apr · Rating
  Dear Sir(s), As per the provisions of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, we are submitting herewith .... (opens in a new tab)
- 18 Apr · Rating
  Credit Rating (opens in a new tab)
- 10 Apr · Disclosure
  Vide letter dated April 06, 2017 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 8 Apr · Compliance Certificate For The Period Ended 31St March, 2017
  SUBMISSION OF COMPLIANCE CERTIFICATE PURSUANT TO REGULATION 7 (3) OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 (opens in a new tab)
- 6 Apr · Disclosure
  Vide letter dated April 5, 2017 a copy of disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 6 Apr · Disclosure
  Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhadra Raj Holdings Pvt Ltd (opens in a new tab)
- 4 Apr · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhadra Raj Holdings Pvt Ltd (opens in a new tab)
- 4 Apr · Disclosure
  Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhadra Raj Holdings Pvt Ltd (opens in a new tab)
Mar 2017
- 28 Mar · News Verification
  Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals Limited with respect to recent news item captioned "US FDA Approves Zejula Capsules.". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Dishman Pharmaceuticals and Chemicals Limited has submitted their response. (opens in a new tab)
- 28 Mar · Updates
  Clarification with reference to the news flashed on CNBC TV18 dated March 28, 2017 quoting "US FDA Approves Zejula Capsules". (opens in a new tab)
- 28 Mar · Legal
  Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals Ltd on March 28, 2017, with reference to the news flashed on CNBC TV18 dated March 28, 2017 quoting "US ....
- 28 Mar · News Verification
  Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals Limited with respect to recent news item captioned "US FDA Approves Zejula Capsules.". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.
- 27 Mar · Business
  Update on Scheme of Arrangement and Amalgamation amongst Dishman Pharmaceuticals and Chemicals Ltd., Carbogen Amcis (India) Limited and Dishman Care Limited and their respective Shareholders & Creditors. (opens in a new tab)
- 27 Mar · Updates
  In terms of our letter dated 17th March, 2017, you are aware that Scheme of Arrangement and Amalgamation amongst Dishman Pharmaceuticals and Chemicals Ltd. ('DPCL'), Carbogen Amcis (India) .... (opens in a new tab)
- 25 Mar · Disclosure
  Vide letter dated March 24, 2017 a copy of disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 24 Mar · Business
  Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, .... (opens in a new tab)
- 17 Mar · Board meeting
  Outcome of meeting of the Board of Directors of the Company held on March 17, 2017. (opens in a new tab)
- 17 Mar · Board meeting
  Meeting of the Board of Directors of the Company was held on today i.e. on 17th day of March, 2017 at Ahmedabad, inter alia, to consider and take on record the Order of Hon'ble High Court .... (opens in a new tab)
- 17 Mar · Business
  Update on Scheme of Arrangement and Amalgamation amongst Dishman Pharmaceuticals and Chemicals Ltd., Carbogen Amcis (India) Limited and Dishman Care Limited and their respective Shareholders & Creditors (opens in a new tab)
- 17 Mar · Updates
  Company has filed the Certified Copy of Order of Hon'ble High Court of Gujarat, sanctioning the Scheme of Arrangement and Amalgamation amongst Dishman Pharmaceuticals and Chemicals .... (opens in a new tab)

How the price met the news

The latest 30. The first session after each announcement, beside the market. Moves to 31 May 2010 are on BSE closes, before the company traded on NSE.

That dayAgainst the Nifty 500Market median on that newsFive sessionsFive sessions against the Nifty 500Volume, times usual

18 Apr 2017Credit ratingdown 4.67%−4.2 pts vs Nifty 500market median 0.0% · five sessions −2.8% (−3.9 pts vs Nifty 500) · volume 0.4× usual · The announcement (opens in a new tab)
14 Feb 2017Dividenddown 3.96%−3.7 pts vs Nifty 500market median 0.0% · five sessions +1.8% (+0.9 pts vs Nifty 500) · volume 2.9× usual · The announcement (opens in a new tab)
6 Feb 2017Dividenddown 2.15%−2.9 pts vs Nifty 500market median 0.0% · five sessions −4.1% (−5.0 pts vs Nifty 500) · volume 1.0× usual · The announcement (opens in a new tab)
10 Mar 2016Dividenddown 2.70%−2.2 pts vs Nifty 500market median 0.0% · five sessions −9.1% (−8.5 pts vs Nifty 500) · volume 0.6× usual
8 Mar 2016Credit ratingup 0.01%−0.1 pts vs Nifty 500market median 0.0% · five sessions +0.3% (−0.4 pts vs Nifty 500) · volume 1.8× usual · The announcement (opens in a new tab)
8 Mar 2016Dividendup 0.01%−0.1 pts vs Nifty 500market median 0.0% · five sessions +0.3% (−0.4 pts vs Nifty 500) · volume 1.8× usual
25 Aug 2015Dividendup 8.02%+6.9 pts vs Nifty 500market median 0.0% · five sessions +19.9% (+17.2 pts vs Nifty 500) · volume 0.9× usual
24 Aug 2015Dividenddown 18.19%−11.5 pts vs Nifty 500market median 0.0% · five sessions −7.2% (−3.4 pts vs Nifty 500) · volume 0.9× usual
17 Aug 2015Dividendup 2.92%+3.1 pts vs Nifty 500market median 0.0% · five sessions +11.1% (+13.3 pts vs Nifty 500) · volume 0.5× usual
13 Jul 2015Dividendup 2.46%+1.3 pts vs Nifty 500market median 0.0% · five sessions +5.0% (+1.9 pts vs Nifty 500) · volume 1.0× usual

20 earlier announcements

5 May 2015Dividendup 0.35%+0.3 pts vs Nifty 500market median 0.0% · five sessions −5.5% (−5.0 pts vs Nifty 500) · volume 0.7× usual
30 Jan 2015Credit ratingdown 0.10%+1.1 pts vs Nifty 500market median 0.0% · five sessions +8.4% (+10.9 pts vs Nifty 500) · volume 1.5× usual · The announcement (opens in a new tab)
8 Oct 2014Credit ratingdown 4.88%−4.7 pts vs Nifty 500market median 0.0% · five sessions −2.0% (−2.3 pts vs Nifty 500) · volume 0.8× usual · The announcement (opens in a new tab)
30 May 2014Dividendup 0.51%+0.4 pts vs Nifty 500market median 0.0% · five sessions +17.8% (+13.6 pts vs Nifty 500) · volume 0.5× usual
29 May 2014Dividenddown 0.06%+1.0 pts vs Nifty 500market median 0.0% · five sessions +12.1% (+10.2 pts vs Nifty 500) · volume 1.1× usual
6 May 2014Dividenddown 1.02%−1.3 pts vs Nifty 500market median 0.0% · five sessions −1.8% (−5.9 pts vs Nifty 500) · volume 1.2× usual
31 Dec 2013Board or managers changedup 5.46%+5.2 pts vs Nifty 500market median 0.0% · five sessions +5.0% (+6.2 pts vs Nifty 500) · volume 2.8× usual
30 May 2013Dividendup 1.76%+1.6 pts vs Nifty 500market median 0.0% · five sessions −4.3% (−2.0 pts vs Nifty 500) · volume 2.2× usual
29 May 2013Dividendup 6.94%+7.2 pts vs Nifty 500market median 0.0% · five sessions +5.6% (+8.2 pts vs Nifty 500) · volume 2.3× usual
28 May 2013Dividenddown 0.36%−0.8 pts vs Nifty 500market median 0.0% · five sessions −0.6% (+1.4 pts vs Nifty 500) · volume 1.2× usual
11 Apr 2013Dividend0.00%−0.5 pts vs Nifty 500market median 0.0% · five sessions −0.4% (−2.5 pts vs Nifty 500) · volume 0.8× usual
1 Aug 2012Dividendup 13.36%+13.0 pts vs Nifty 500market median 0.0% · five sessions +24.6% (+22.6 pts vs Nifty 500) · volume 10.8× usual
31 Jul 2012Dividendup 6.75%+6.2 pts vs Nifty 500market median 0.0% · five sessions +24.8% (+23.2 pts vs Nifty 500) · volume 3.7× usual
23 Jul 2012Dividenddown 4.07%−2.5 pts vs Nifty 500market median 0.0% · five sessions −6.0% (−3.4 pts vs Nifty 500) · volume 0.7× usual
30 May 2011Dividendup 1.38%+1.1 pts vs Nifty 500market median 0.0% · five sessions −0.4% (−1.5 pts vs Nifty 500) · volume 2.4× usual
27 May 2011Dividenddown 1.15%−2.4 pts vs Nifty 500market median 0.0% · five sessions +0.9% (−2.0 pts vs Nifty 500) · volume 3.2× usual
3 May 2011Dividenddown 2.30%−0.1 pts vs Nifty 500market median 0.0% · five sessions −5.1% (−2.7 pts vs Nifty 500) · volume 0.3× usual
31 May 2010Dividenddown 3.06%−4.0 pts vs Nifty 500market median 0.0% · five sessions −5.8% (−7.7 pts vs Nifty 500) · volume 1.0× usual
3 May 2010Dividendup 0.62%+1.2 pts vs Nifty 500market median 0.0% · five sessions −1.1% (+3.1 pts vs Nifty 500) · volume 0.4× usual
8 Jul 2009Dividenddown 3.80%−1.5 pts vs Nifty 500market median 0.0% · five sessions +3.5% (+5.3 pts vs Nifty 500) · volume 0.6× usual

Sharp moves

The latest 30. 12 of the 30 shown had no filing that day or the next. Moves to 22 Jun 2010 are on BSE closes, before the company traded on NSE.

MoveAgainst the Nifty 500Times its usual moveVolume, times usualFilings

3 Apr 20172 filingsup 12.44%+11.7 pts vs Nifty 5003.3× its usual move · volume 5.5× usual
28 Mar 20176 filingsup 20.00%+19.4 pts vs Nifty 5007.9× its usual move · volume 2.6× usual
9 Jan 2017No filing that day or the nextup 10.62%+10.6 pts vs Nifty 5004.4× its usual move · volume 8.0× usual
30 Sep 2016No filing that day or the nextup 15.22%+14.4 pts vs Nifty 5004.8× its usual move · volume 3.6× usual
4 Aug 20163 filingsup 7.35%+7.1 pts vs Nifty 5003.1× its usual move · volume 2.6× usual
17 Nov 20154 filingsdown 14.04%−14.5 pts vs Nifty 5002.7× its usual move · volume 4.5× usual
1 Oct 20152 filingsup 10.89%+10.8 pts vs Nifty 5002.2× its usual move · volume 2.7× usual
23 Sep 20152 filingsup 16.22%+15.8 pts vs Nifty 5003.5× its usual move · volume 3.7× usual
2 Sep 2015No filing that day or the nextup 15.53%+16.2 pts vs Nifty 5003.8× its usual move · volume 8.1× usual
24 Aug 201513 filingsdown 18.19%−11.5 pts vs Nifty 5005.8× its usual move · volume 0.9× usual

20 earlier moves

28 Jan 20152 filingsup 16.13%+16.0 pts vs Nifty 5005.2× its usual move · volume 8.9× usual
13 Nov 20147 filingsdown 11.75%−11.4 pts vs Nifty 5003.2× its usual move · volume 4.1× usual
13 Aug 20145 filingsdown 12.79%−12.5 pts vs Nifty 5003.9× its usual move · volume 1.8× usual
16 Jun 20143 filingsup 9.44%+9.5 pts vs Nifty 5003.2× its usual move · volume 1.6× usual
4 Jun 2014No filing that day or the nextup 10.70%+10.4 pts vs Nifty 5004.3× its usual move · volume 6.1× usual
30 Jan 2014No filing that day or the nextdown 11.04%−10.1 pts vs Nifty 5003.0× its usual move · volume 2.2× usual
27 Jan 20142 filingsdown 13.54%−11.2 pts vs Nifty 5003.9× its usual move · volume 1.4× usual
18 Dec 20132 filingsup 11.79%+10.5 pts vs Nifty 5003.0× its usual move · volume 10.3× usual
1 Oct 2013No filing that day or the nextup 17.10%+16.4 pts vs Nifty 5004.5× its usual move · volume 6.7× usual
5 Aug 20132 filingsup 9.88%+9.7 pts vs Nifty 5003.1× its usual move · volume 0.6× usual
26 Feb 20132 filingsdown 8.28%−6.7 pts vs Nifty 5003.4× its usual move · volume 1.5× usual
1 Aug 20125 filingsup 13.36%+13.0 pts vs Nifty 5004.4× its usual move · volume 10.8× usual
25 May 2012No filing that day or the nextup 10.74%+10.6 pts vs Nifty 5005.5× its usual move · volume 5.2× usual
10 Jan 2012No filing that day or the nextup 13.07%+10.8 pts vs Nifty 5004.6× its usual move · volume 7.5× usual
18 Nov 2011No filing that day or the nextup 6.94%+7.6 pts vs Nifty 5003.8× its usual move · volume 1.2× usual
21 Jul 20111 filingup 6.47%+7.0 pts vs Nifty 5003.6× its usual move · volume 17.8× usual
20 Jun 20112 filingsdown 6.88%−4.7 pts vs Nifty 5003.9× its usual move · volume 1.1× usual
14 Feb 2011No filing that day or the nextdown 9.42%−12.4 pts vs Nifty 5003.5× its usual move · volume 13.2× usual
2 Dec 2010No filing that day or the nextup 10.11%+9.3 pts vs Nifty 5005.1× its usual move · volume 5.4× usual
22 Jun 2010No filing that day or the nextup 6.50%+7.0 pts vs Nifty 5003.9× its usual move · volume 4.1× usual

Last results date

Dishman Pharmaceuticals & Chemicals annual reports, presentations and earnings calls

Annual reports14

Investor presentations5

Earnings calls7

Dishman Pharmaceuticals & Chemicals share news and announcements

Sep 2017

Aug 2017

Jul 2017

Jun 2017

May 2017

Apr 2017

Mar 2017

How the price met the news

Sharp moves